Tissue engineering, stem cells, cloning, and parthenogenesis: New paradigms for therapy

Jason Hipp, Anthony Atala

Research output: Contribution to journalArticle

35 Citations (Scopus)

Abstract

Background: Patients suffering from diseased and injured organs may be treated with transplanted organs. However, there is a severe shortage of donor organs which is worsening yearly due to the aging population. Scientists in the field of tissue engineering apply the principles of cell transplantation, materials science, and bioengineering to construct biological substitutes that will restore and maintain normal function in diseased and injured tissues. Both therapeutic cloning (nucleus from a donor cell is transferred into an enucleated oocyte), and parthenogenesis (oocyte is activated and stimulated to divide), permit extraction of pluripotent embryonic stem cells, and offer a potentially limitless source of cells for tissue engineering applications. The stem cell field is also advancing rapidly, opening new options for therapy. The present article reviews recent progress in tissue engineering and describes applications of these new technologies that may offer novel therapies for patients with end-stage organ failure.

Original languageEnglish
JournalJournal of Experimental and Clinical Assisted Reproduction
Volume1
DOIs
StatePublished - Dec 8 2004
Externally publishedYes

Fingerprint

Parthenogenesis
Tissue Engineering
Organism Cloning
Stem Cells
Oocytes
Tissue Donors
Cell Engineering
Bioengineering
Pluripotent Stem Cells
Cell Transplantation
Embryonic Stem Cells
Therapeutics
Technology
Population

ASJC Scopus subject areas

  • Obstetrics and Gynecology

Cite this

Tissue engineering, stem cells, cloning, and parthenogenesis : New paradigms for therapy. / Hipp, Jason; Atala, Anthony.

In: Journal of Experimental and Clinical Assisted Reproduction, Vol. 1, 08.12.2004.

Research output: Contribution to journalArticle

@article{33f2d6454bfc4146acb1fa5897866cd4,
title = "Tissue engineering, stem cells, cloning, and parthenogenesis: New paradigms for therapy",
abstract = "Background: Patients suffering from diseased and injured organs may be treated with transplanted organs. However, there is a severe shortage of donor organs which is worsening yearly due to the aging population. Scientists in the field of tissue engineering apply the principles of cell transplantation, materials science, and bioengineering to construct biological substitutes that will restore and maintain normal function in diseased and injured tissues. Both therapeutic cloning (nucleus from a donor cell is transferred into an enucleated oocyte), and parthenogenesis (oocyte is activated and stimulated to divide), permit extraction of pluripotent embryonic stem cells, and offer a potentially limitless source of cells for tissue engineering applications. The stem cell field is also advancing rapidly, opening new options for therapy. The present article reviews recent progress in tissue engineering and describes applications of these new technologies that may offer novel therapies for patients with end-stage organ failure.",
author = "Jason Hipp and Anthony Atala",
year = "2004",
month = "12",
day = "8",
doi = "10.1186/1743-1050-1-3",
language = "English",
volume = "1",
journal = "Journal of Experimental and Clinical Assisted Reproduction",
issn = "1743-1050",
publisher = "BioMed Central",

}

TY - JOUR

T1 - Tissue engineering, stem cells, cloning, and parthenogenesis

T2 - New paradigms for therapy

AU - Hipp, Jason

AU - Atala, Anthony

PY - 2004/12/8

Y1 - 2004/12/8

N2 - Background: Patients suffering from diseased and injured organs may be treated with transplanted organs. However, there is a severe shortage of donor organs which is worsening yearly due to the aging population. Scientists in the field of tissue engineering apply the principles of cell transplantation, materials science, and bioengineering to construct biological substitutes that will restore and maintain normal function in diseased and injured tissues. Both therapeutic cloning (nucleus from a donor cell is transferred into an enucleated oocyte), and parthenogenesis (oocyte is activated and stimulated to divide), permit extraction of pluripotent embryonic stem cells, and offer a potentially limitless source of cells for tissue engineering applications. The stem cell field is also advancing rapidly, opening new options for therapy. The present article reviews recent progress in tissue engineering and describes applications of these new technologies that may offer novel therapies for patients with end-stage organ failure.

AB - Background: Patients suffering from diseased and injured organs may be treated with transplanted organs. However, there is a severe shortage of donor organs which is worsening yearly due to the aging population. Scientists in the field of tissue engineering apply the principles of cell transplantation, materials science, and bioengineering to construct biological substitutes that will restore and maintain normal function in diseased and injured tissues. Both therapeutic cloning (nucleus from a donor cell is transferred into an enucleated oocyte), and parthenogenesis (oocyte is activated and stimulated to divide), permit extraction of pluripotent embryonic stem cells, and offer a potentially limitless source of cells for tissue engineering applications. The stem cell field is also advancing rapidly, opening new options for therapy. The present article reviews recent progress in tissue engineering and describes applications of these new technologies that may offer novel therapies for patients with end-stage organ failure.

UR - http://www.scopus.com/inward/record.url?scp=15744400422&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=15744400422&partnerID=8YFLogxK

U2 - 10.1186/1743-1050-1-3

DO - 10.1186/1743-1050-1-3

M3 - Article

AN - SCOPUS:15744400422

VL - 1

JO - Journal of Experimental and Clinical Assisted Reproduction

JF - Journal of Experimental and Clinical Assisted Reproduction

SN - 1743-1050

ER -